Amandine Blanc

PKC ζ–mTOR pathway: a new target for rituximab therapy in follicular lymphoma

L. Leseux, Guy Laurent, Camille Laurent et al. · Blood · 2007 · 62 citations · Full text

Immune recovery after fludarabine–cyclophosphamide–rituximab treatment in B-chronic lymphocytic leukemia: implication for maintenance immunotherapy

Loïc Ysebaert, Emilie Gross, Emilienne Kühlein et al. · Leukemia · 2010 · 57 citations

Fludarabine–cyclophosphamide–rituximab Treatment, Lymphoid Neoplasia, Hematological Malignancy +11

Cell Growth in Aggregates Determines Gene Expression, Proliferation, Survival, Chemoresistance, and Sensitivity to Immune Effectors in Follicular Lymphoma

Pauline Gravelle, Christine Jean, J Familiadès et al. · American Journal Of Pathology · 2013 · 40 citations · Full text

Lymphoid Neoplasia, Cancer Immunosurveillance, Immune Effectors +7

Epidermal Growth Factor Receptor/β-Catenin/T-Cell Factor 4/Matrix Metalloproteinase 1: A New Pathway for Regulating Keratinocyte Invasiveness after UVA Irradiation

Christine Jean, Amandine Blanc, Naïs Prade-Houdellier et al. · Cancer Research · 2009 · 27 citations · Full text

Uva Irradiation, Dermatology, Uva Injury +20

Endogenous IL-8 acts as a CD16 co-activator for natural killer-mediated anti-CD20 B cell depletion in chronic lymphocytic leukemia

Emilie Laprévotte, Loïc Ysebaert, Christian Klein et al. · Leukemia Research · 2012 · 23 citations

Cd16 Co-activator, Chronic Lymphocytic Leukemia, Malignant Blood Disorder +8